Evaluating the biopsychosocial milieu of chronic pain

Mary Elizabeth Turner, Marian Fireman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The biopsychosocial model was developed in the 1970s in psychiatry and spread to other fields, gaining special prominence in chronic pain assessments. Currently, most treatment guidelines for chronic pain recommend psychosocial assessments for all patients and multidisciplinary biopsychosocial assessments for patients who fail to respond to routine treatment or patients with complicating psychopathology, including substance usage. There is strong evidence for the association between chronic pain and psychosocial factors and for the efficacy of psychosocial treatments in chronic pain. However, there is limited existing evidence showing the benefits of performing a multidisciplinary biopsychosocial assessment largely due to limited randomized controlled trials. This chapter explores the history of the biopsychosocial model, evidence in support of its usage, and provides tips on performing this assessment. We include a section on special concerns for patients with substance use disorders.

Original languageEnglish (US)
Title of host publicationTreating Comorbid Opioid Use Disorder in Chronic Pain
PublisherSpringer International Publishing
Pages35-46
Number of pages12
ISBN (Electronic)9783319298634
ISBN (Print)9783319298610
DOIs
StatePublished - Jan 1 2016

Fingerprint

Chronic Pain
Pain Measurement
Psychopathology
Substance-Related Disorders
Psychiatry
Randomized Controlled Trials
History
Guidelines
Psychology
Therapeutics

Keywords

  • Biopsychosocial model
  • Chronic pain
  • Developmental history
  • Disability
  • Opioid use disorder
  • Psychological testing
  • Substance usage

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Turner, M. E., & Fireman, M. (2016). Evaluating the biopsychosocial milieu of chronic pain. In Treating Comorbid Opioid Use Disorder in Chronic Pain (pp. 35-46). Springer International Publishing. https://doi.org/10.1007/978-3-319-29863-4_4

Evaluating the biopsychosocial milieu of chronic pain. / Turner, Mary Elizabeth; Fireman, Marian.

Treating Comorbid Opioid Use Disorder in Chronic Pain. Springer International Publishing, 2016. p. 35-46.

Research output: Chapter in Book/Report/Conference proceedingChapter

Turner, ME & Fireman, M 2016, Evaluating the biopsychosocial milieu of chronic pain. in Treating Comorbid Opioid Use Disorder in Chronic Pain. Springer International Publishing, pp. 35-46. https://doi.org/10.1007/978-3-319-29863-4_4
Turner ME, Fireman M. Evaluating the biopsychosocial milieu of chronic pain. In Treating Comorbid Opioid Use Disorder in Chronic Pain. Springer International Publishing. 2016. p. 35-46 https://doi.org/10.1007/978-3-319-29863-4_4
Turner, Mary Elizabeth ; Fireman, Marian. / Evaluating the biopsychosocial milieu of chronic pain. Treating Comorbid Opioid Use Disorder in Chronic Pain. Springer International Publishing, 2016. pp. 35-46
@inbook{bc1f7e32776d413fa82be4cb35e89e91,
title = "Evaluating the biopsychosocial milieu of chronic pain",
abstract = "The biopsychosocial model was developed in the 1970s in psychiatry and spread to other fields, gaining special prominence in chronic pain assessments. Currently, most treatment guidelines for chronic pain recommend psychosocial assessments for all patients and multidisciplinary biopsychosocial assessments for patients who fail to respond to routine treatment or patients with complicating psychopathology, including substance usage. There is strong evidence for the association between chronic pain and psychosocial factors and for the efficacy of psychosocial treatments in chronic pain. However, there is limited existing evidence showing the benefits of performing a multidisciplinary biopsychosocial assessment largely due to limited randomized controlled trials. This chapter explores the history of the biopsychosocial model, evidence in support of its usage, and provides tips on performing this assessment. We include a section on special concerns for patients with substance use disorders.",
keywords = "Biopsychosocial model, Chronic pain, Developmental history, Disability, Opioid use disorder, Psychological testing, Substance usage",
author = "Turner, {Mary Elizabeth} and Marian Fireman",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-29863-4_4",
language = "English (US)",
isbn = "9783319298610",
pages = "35--46",
booktitle = "Treating Comorbid Opioid Use Disorder in Chronic Pain",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Evaluating the biopsychosocial milieu of chronic pain

AU - Turner, Mary Elizabeth

AU - Fireman, Marian

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The biopsychosocial model was developed in the 1970s in psychiatry and spread to other fields, gaining special prominence in chronic pain assessments. Currently, most treatment guidelines for chronic pain recommend psychosocial assessments for all patients and multidisciplinary biopsychosocial assessments for patients who fail to respond to routine treatment or patients with complicating psychopathology, including substance usage. There is strong evidence for the association between chronic pain and psychosocial factors and for the efficacy of psychosocial treatments in chronic pain. However, there is limited existing evidence showing the benefits of performing a multidisciplinary biopsychosocial assessment largely due to limited randomized controlled trials. This chapter explores the history of the biopsychosocial model, evidence in support of its usage, and provides tips on performing this assessment. We include a section on special concerns for patients with substance use disorders.

AB - The biopsychosocial model was developed in the 1970s in psychiatry and spread to other fields, gaining special prominence in chronic pain assessments. Currently, most treatment guidelines for chronic pain recommend psychosocial assessments for all patients and multidisciplinary biopsychosocial assessments for patients who fail to respond to routine treatment or patients with complicating psychopathology, including substance usage. There is strong evidence for the association between chronic pain and psychosocial factors and for the efficacy of psychosocial treatments in chronic pain. However, there is limited existing evidence showing the benefits of performing a multidisciplinary biopsychosocial assessment largely due to limited randomized controlled trials. This chapter explores the history of the biopsychosocial model, evidence in support of its usage, and provides tips on performing this assessment. We include a section on special concerns for patients with substance use disorders.

KW - Biopsychosocial model

KW - Chronic pain

KW - Developmental history

KW - Disability

KW - Opioid use disorder

KW - Psychological testing

KW - Substance usage

UR - http://www.scopus.com/inward/record.url?scp=84978230471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978230471&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-29863-4_4

DO - 10.1007/978-3-319-29863-4_4

M3 - Chapter

AN - SCOPUS:84978230471

SN - 9783319298610

SP - 35

EP - 46

BT - Treating Comorbid Opioid Use Disorder in Chronic Pain

PB - Springer International Publishing

ER -